WallStreetZenWallStreetZen

NASDAQ: SYNH
Syneos Health Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SYNH past earnings growth

How has SYNH's earnings growth performed historically?
Company
-38.03%
Industry
-1.88%
Market
14.45%
SYNH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SYNH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

SYNH past revenue growth

How has SYNH's revenue growth performed historically?
Company
1.37%
Industry
5.94%
Market
14.01%
SYNH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SYNH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SYNH's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SYNH earnings and revenue history

Current Revenue
$5.4B
Current Earnings
$148.2M
Current Profit Margin
2.7%

SYNH Return on Equity

Current Company
4.3%
Current Industry
-180.9%
Current Market
30.8%
SYNH's Return on Equity (4.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SYNH announces earnings.

SYNH Return on Assets

Current Company
1.8%
Current Industry
5.6%
SYNH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SYNH Return on Capital Employed

Current Company
4.36%
Current Industry
9.8%
SYNH's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SYNH vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SYNH$5.41B$525.89M$148.17M+10.09%+68.47%
SHC$987.52M-$35.32M-$261.37M+8.29%N/A
NEOG$720.73M$93.02M-$13.48M+13.34%-41.12%
PACB$134.03M-$288.50M-$320.76M+8.80%N/A
GH$482.15M-$600.17M-$664.89M+44.50%N/A
View Top Diagnostic & Research Stocks

SYNH earnings dates

Next earnings date
Jul 31, 2023

Syneos Health Earnings & Revenue FAQ

What were SYNH's earnings last quarter?

On Invalid Date, Syneos Health (NASDAQ: SYNH) reported Q1 2023 earnings per share (EPS) of -$0.70, up 255.56% year over year. Total Syneos Health earnings for the quarter were -$72.15 million. In the same quarter last year, Syneos Health's earnings per share (EPS) was $0.45.

If you're new to stock investing, here's how to buy Syneos Health stock.

What was SYNH's earnings growth in the past year?

As of Q2 2023, Syneos Health's earnings has grown -38.03% year over year. This is 36.15 percentage points lower than the US Diagnostics & Research industry earnings growth rate of -1.88%. Syneos Health's earnings in the past year totalled $148.17 million.

What is SYNH's earnings date?

Syneos Health's earnings date is Invalid Date. Add SYNH to your watchlist to be reminded of SYNH's next earnings announcement.

What was SYNH's revenue last quarter?

On Invalid Date, Syneos Health (NASDAQ: SYNH) reported Q1 2023 revenue of $1.36 billion up 1.54% year over year. In the same quarter last year, Syneos Health's revenue was $1.34 billion.

What was SYNH's revenue growth in the past year?

As of Q2 2023, Syneos Health's revenue has grown 1.37% year over year. This is 4.57 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 5.94%. Syneos Health's revenue in the past year totalled $5.41 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.